Eka Funding
Book a demo
New Lipid Blood Test Reveals Hidden Pediatric Risks
Researchers at King’s College London have developed a new blood test that may allow clinicians to identify children at higher risk of conditions such as type 2 diabetes, liver, and heart disease. This innovative approach focuses on a broader range of lipids rather than traditional cholesterol and triglyceride measurements.
on
February 18, 2025
ICMR Invites Collaboration for Cutting-Edge Typhoid and Paratyphoid Vaccine
The Indian Council of Medical Research (ICMR) has opened its doors to private partners for the joint development and commercialisation of a novel vaccine targeting both typhoid and paratyphoid. This technology, developed at ICMR-National Institute for Research in Bacterial Infections (NIRBI), Kolkata, harnesses outer membrane vesicles derived from Salmonella Typhi, Salmonella Paratyphi, and Salmonella Typhimurium.
on
February 17, 2025
Cardiac Device Repurposed to Repair Complex Fistulas: A Game-Changer for Gastroenterology
Despite multiple failed surgeries following radiation therapy for cervical cancer and other complications, these patients found renewed hope when referred to Dr. Anil Arora and Dr. Shivam Khare. By ingeniously repurposing a cardiac occluder device, typically used to treat structural heart defects, the doctors sealed the rectovaginal and enterovaginal fistulas through a minimally invasive endoscopic approach. Pediatric cardiologist Dr. Neeraj Agrawal assisted in adapting the device to ensure a robust closure and quicker recovery.
on
February 15, 2025
Revolutionizing Neurological Care: AIIMS Adopts MR-Guided HIFU
MR-Guided High-Intensity Focused Ultrasound (HIFU) system. This advanced technology uses MRI-guided ultrasound waves to precisely target affected brain regions, offering a promising alternative for treating Parkinson’s disease, essential tremors, and potentially epilepsy, neuropathic pain, OCD, and even facilitating enhanced drug delivery via blood–brain barrier modulation.
on
February 14, 2025
Estradiol Transdermal Patch Promises Fewer Androgen Deprivation Therapy Side Effects
A mid-stage trial presented at the 2025 ASCO Genitourinary Cancers Symposium in San Francisco is sparking interest among oncologists. In the study led by Dr. Nick James at The Royal Marsden NHS Foundation Trust, 79 prostate cancer patients receiving androgen receptor pathway inhibitors were randomized to standard LHRH therapy or a transdermal patch delivering estradiol.
on
February 13, 2025
Next
Featured
New Lipid Blood Test Reveals Hidden Pediatric Risks
ICMR Invites Collaboration for Cutting-Edge Typhoid and Paratyphoid Vaccine
Cardiac Device Repurposed to Repair Complex Fistulas: A Game-Changer for Gastroenterology
Revolutionizing Neurological Care: AIIMS Adopts MR-Guided HIFU
Estradiol Transdermal Patch Promises Fewer Androgen Deprivation Therapy Side Effects
Participate in India’s healthcare revolution
Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)
Create ABHA ID
Popular topics
#
newfeature
#
Partnership
#
funding